Nivolumab Monotherapy is Safe and Active in Hematologic Malignancies

from Journal of Clinical Oncology (JCO) Podcast · host Jason R. Westin

This podcast is a discussion of a clinical trial by Lesokhin et al which evaluated nivolumab monotherapy in patients with relapsed or refractory hematologic malignancies.

Episode metadata supplied by the publisher feed · Published Jul 14, 2016

Embed this episode

Attribution link and audio player

NOW PLAYING

Nivolumab Monotherapy is Safe and Active in Hematologic Malignancies

0:00 9:21

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Journal of Clinical Oncology (JCO) Podcast?

This episode is 9 minutes long.

When was this Journal of Clinical Oncology (JCO) Podcast episode published?

This episode was published on July 14, 2016.

Can I download this Journal of Clinical Oncology (JCO) Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!